C-Reactive Protein and Other Emerging Blood Biomarkers to Optimize Risk Stratification of Vulnerable Patients
Top Cited Papers
- 1 April 2006
- journal article
- review article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 47 (8) , C19-C31
- https://doi.org/10.1016/j.jacc.2005.10.066
Abstract
No abstract availableKeywords
This publication has 132 references indexed in Scilit:
- Oxidized Phospholipids, Lp(a) Lipoprotein, and Coronary Artery DiseaseNew England Journal of Medicine, 2005
- The effect of statin therapy on lipoprotein associated phospholipase A2 levelsAtherosclerosis, 2005
- Low-Density Lipoprotein Subfractions and the Long-Term Risk of Ischemic Heart Disease in MenArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Inflammatory Markers and the Risk of Coronary Heart Disease in Men and WomenNew England Journal of Medicine, 2004
- Circulating Oxidized Low-Density Lipoprotein and Its Association With Carotid Intima-Media Thickness in Asymptomatic Members of Familial Combined Hyperlipidemia FamiliesArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Myeloperoxidase and Plaque VulnerabilityArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Circulating oxidized low-density lipoprotein is an independent predictor for cardiac event in patients with coronary artery diseaseAtherosclerosis, 2004
- Increased Thrombosis After Arterial Injury in Human C-Reactive Protein–Transgenic MiceCirculation, 2003
- Improvement of coronary artery endothelial dysfunction with lipid-lowering therapy: heterogeneity of segmental response and correlation with plasma-oxidized low density lipoproteinJournal of the American College of Cardiology, 2001
- Lipoprotein-Associated Phospholipase A 2 , Platelet-Activating Factor Acetylhydrolase, Is Expressed by Macrophages in Human and Rabbit Atherosclerotic LesionsArteriosclerosis, Thrombosis, and Vascular Biology, 1999